Search
Schrodinger Inc
SDGRAdd to Watchlist
16.880USD
+0.490+2.99%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.26BMarket Cap
LossP/E TTM
More Details of Schrodinger Inc Company
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.
Schrodinger Inc Info
Ticker SymbolSDGR
Company nameSchrodinger Inc
IPO dateFeb 06, 2020
CEOFarid (Ramy Farid)
Number of employees891
Security typeOrdinary Share
Fiscal year-endFeb 06
Address1540 Broadway
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10036
Phone15032991150
Websitehttps://www.schrodinger.com
Ticker SymbolSDGR
IPO dateFeb 06, 2020
CEOFarid (Ramy Farid)
Company Executives of Schrodinger Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.41M
+0.58%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
72.66K
+50.36%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
24.57K
-5.68%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
19.39K
+41.98%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
19.39K
+41.98%
Ms. Bridget Anne Van Kralingen
Ms. Bridget Anne Van Kralingen
Independent Director
Independent Director
11.47K
+70.95%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President, Chief Legal Officer
Chief People Officer, Executive Vice President, Chief Legal Officer
10.49K
-402.13%
Dr. Ramy Farid, Ph.D.
Dr. Ramy Farid, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Robert Abel, Ph.D.
Dr. Robert Abel, Ph.D.
Executive Vice President, Chief Scientific Officer, Platform
Executive Vice President, Chief Scientific Officer, Platform
--
--
Dr. Karen Akinsanya, Ph.D.
Dr. Karen Akinsanya, Ph.D.
President - R&D Therapeutics
President - R&D Therapeutics
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.41M
+0.58%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
72.66K
+50.36%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
24.57K
-5.68%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
19.39K
+41.98%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
19.39K
+41.98%
Ms. Bridget Anne Van Kralingen
Ms. Bridget Anne Van Kralingen
Independent Director
Independent Director
11.47K
+70.95%
FAQs
Who are the top five shareholders of Schrodinger Inc?
The top five shareholders of Schrodinger Inc are: Dr. Richard A. Friesner, Ph.D.
How many institutions hold shares of Schrodinger Inc (SDGR)?
As of 2026Q1, 525 institutions hold shares of Schrodinger Inc, with a combined market value of approximately 71.93M, accounting for 109.89% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -7222611.00.
What is the biggest source of revenue for Schrodinger Inc?
In 2026Q1, the On-premise software business generated the highest revenue for Schrodinger Inc, amounting to 101.45M and accounting for 39.65% of total revenue.